Long-Term Prediction Model for Hepatocellular Carcinoma in Patients with Chronic Hepatitis B Receiving Antiviral Therapy: Based on Data from Korean Patients

Predicting the development of hepatocellular carcinoma (HCC) is a key clinical issue in patients with chronic hepatitis B (CHB). The aim of this study was to develop a precise and simple HCC risk score for up to 10 years. A total of 1895 CHB patients treated with entecavir or tenofovir disoproxil fu...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Ji Hun, Shin, Seung Kak, Kang, Seong Hee, Kim, Tae Hyung, Yim, Hyung Joon, Yim, Sun Young, Lee, Young-Sun, Jung, Young Kul, Kim, Ji Hoon, Seo, Yeon Seok, Yeon, Jong Eun, Kwon, Oh Sang, Um, Soon Ho, Byun, Kwan Soo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9697157/
https://www.ncbi.nlm.nih.gov/pubmed/36431090
http://dx.doi.org/10.3390/jcm11226613

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9697157/
https://www.ncbi.nlm.nih.gov/pubmed/36431090
http://dx.doi.org/10.3390/jcm11226613

Ejemplares similares